Daten aus dem Cache geladen. Esophageal Cancer Market research,Advancement, Comprehensive...

Esophageal Cancer Market research,Advancement, Comprehensive Analysis and Developments Status 2030

0
2كيلو بايت

Esophageal Cancer Market Overview

Rated the sixth most common type of cancer affecting patients, esophageal cancer is responsible for numerus deaths worldwide. Tobacco and alcohol consumption, or certain dietary habits can lead to probabilities of attaining the disease. With advances in treatment, diagnostics, and surgical techniques, the prognosis rate of esophageal cancer has improved considerably over the ears. In addition, increase in survival rates, detection at an early stage, and transformation in the field of drug development have all worked in favor of the global Esophageal Cancer Market Research.

Cancer is one of the leading causes of death worldwide and is expected to witness the expansion of patient population in the years to come. One of the types of cancer that affect the food pipe connecting the mouth and stomach is the esophageal cancer which is majorly prevalent among the older adults belonging to 55 years and above age group. Market Research Future (MRFR) has found out that Esophageal Cancer Market Share is projected to reach USD 22 billion at CAGR of 8.22% by 2030.

Historically, esophageal cancer had limited treatment options. However, recent treatment advances are aiding patients to opt for treatment options that can possibly help them live longer with less side effects. Intensive R&D activities and clinical trials are being carried out at an accelerated pace. Combination of various therapies such as chemotherapy with immunotherapy have demonstrated significant improvement in response rates. Of late, the FDA has also been approving more immunotherapy drugs for a variety of oncological disorders, which is likely to uplift the development of the esophageal cancer market.

Market Segmentation

By type, the global Esophageal Cancer Market Report has been segmented into esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others.

On the basis of phase, the Esophageal Cancer Market Trends has been segmented into phase I, phases II, and phases III.

The esophageal cancer market by treatment, has been segmented into surgery, chemotherapy and radiotherapy and other.

Regional Analysis

Region-wise, the esophageal cancer market has been segmented into North America, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.

With numerous cases of esophageal cancer, North America has commanded the leading position in the global market. The population of the region is highly addicted to tobacco, which remains among the prime causes of esophageal cancer. High government support, high healthcare expenditure, and favorable reimbursement landscape is providing impetus to the growth of the North America market. The US has major contribution to make in the North America market. Robust healthcare infrastructure and the presence of a wide population base supports the growth of the market.

Intensive R&D activities in Europe is driving the growth of the market in Europe. The expansion of the APAC market can be attributed to the surging incidence rate of esophageal cancer and large unmet needs in the region.

Competitive Landscape

Esophageal Cancer Market Players includeAmgen Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Johnson & Johnson (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline Plc. (U.K), Bristol-Myers Squibb (U.S.), Bristol-Myers Squibb Company (U.S.), and Gilead Sciences, Inc. (U.S.) are the eminent players in the global market.

Industry Updates

August 2019 - A new immunotherapy drug has been approved by the U.S. Food and Drug Administration (FDA) aimed at treating esophageal cancer. Dubbed as “Keytruda", the new immunotherapy drug pembrolizumab has exhibited its efficiency in reducing the risk of fatality in esophageal cancer patients by 31% in clinical trials. The treatment would be beneficial for those patients who are unresponsive to chemotherapy. Keytruda is the result of aggressive R&D by the leading pharmaceutical company, Merck & Co.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

 

 

 

 

البحث
الأقسام
إقرأ المزيد
أخرى
Pepper Sprays: The Complete Guide to Peppercorn for Self Defense In Industry
History and Development of Pepper SpraysPeppercorn were originally developed in the 1960s for use...
بواسطة Ashwini Bakhade 2024-09-26 13:49:11 0 317
الألعاب
Scopri i Prezzi Giocatori FC 25: Analisi e Tendenze del Mercato Calcistico
Scopri i Prezzi Giocatori FC 25: Analisi e Tendenze del Mercato Calcistico Nel vasto universo del...
بواسطة Minorescu Jone 2025-02-13 23:58:21 0 28
Health
Alternative Medicines Therapies Market Market Dynamics Research | Size, Trends, and Competitive Landscape 2024 - 2032
Alternative medicine therapies can leverage healthcare AI by analyzing patient data to suggest...
بواسطة Sophia Grant 2024-12-07 11:24:46 0 98
Gardening
"자동차: 무한한 가능성과 진화의 역사
자동차는 현대 삶에서 더 이상 생각할 수 없는 필수품 중 하나로 자리 잡고 있습니다. 이동성, 편리성, 그리고 문화와 경제적 영향력 때문에 자동차는 우리의 일상에서 빼놓을 수...
بواسطة Traveltourism Traveltourism 2023-10-31 10:32:53 0 1K
الألعاب
Everything to Know About the New Updates in CS: GO
Games like Counter-Strike always carry the charm every gamer seeks. CS and CS: GO have millions...
بواسطة Elisa Wilson 2020-12-10 06:44:40 0 2K